AMYE BANASZAK: Open Payments
NPI 1306240064 · BRIDGEVILLE, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$961 in 103 payments from 8 companies in 2025. Trend: 2023 $25 · 2024 $892 · 2025 $961
Food & beverage: $961
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 22 | $263 |
| Supernus Pharmaceuticals, Inc. | 28 | $188 |
| Lundbeck LLC | 29 | $183 |
| Collegium Pharmaceutical, Inc. | 17 | $162 |
| Bausch Health US, LLC | 4 | $85 |
| Alkermes, Inc. | 1 | $33 |
| Neurocrine BioSciences, Inc. | 1 | $33 |
| Otsuka America Pharmaceutical, Inc. | 1 | $14 |
Products named: VRAYLAR, REXULTI, Qelbree, Jornay PM, APLENZIN, LYBALVI, INGREZZA.
Industry payments across PA — which companies pay providers there.
